March 9, 2026
TOPLINE: Major depressive disorder (MDD) was prevalent among 32% of all individuals with cannabis use disorder (CUD) in a new meta-analysis, and CUD was prevalent among […]
March 6, 2026
TOPLINE: Mindfulness-based auditory hallucination management (MBAHM) added to routine care for 8 weeks was associated with a greater reduction in auditory hallucinations, anxiety, and depression, as […]
March 6, 2026
TOPLINE: Childbirth-related posttraumatic stress symptoms (CB-PTSS) affected up to 13% of mothers and 1.3% of co-parents. Subjective birth perception was a key risk factor for CB-PTSS […]
March 3, 2026
A group of leading autism researchers has struck an independent advisory committee to respond to non-evidence-based claims about the condition by a long-standing federal panel. The […]
March 2, 2026
University of Ottawa researchers have been studying a concept that might one day allow functionally limited patients with depression to enjoy the mood-boosting benefits of exercise. […]
March 2, 2026
New research challenges the assumption that long-term cannabis use improves symptoms or functioning in post-traumatic stress disorder (PTSD). On the contrary, researchers found that abstaining from […]
March 2, 2026
Adults with intellectual and developmental disabilities (IDDs) are far more likely to experience anxiety and depression than the general population. New national data from more than […]
February 27, 2026
TOPLINE: Individuals gambling at least two times a week were nearly 15-fold more likely to be in the low-risk category, nearly 38-fold more likely to be […]
February 26, 2026
A new expert consensus statement from the American Society of Clinical Psychopharmacology offered clinical guidance on when and whether to discontinue psychiatric medications. The statement, developed […]